In a STAT3/ERK1,2-dependent manner, IL-6 promoted proliferation and survival of tumor cells, protected them from drug-induced apoptosis in vitro and stimulated tumor growth in vivo [135]. The gene discussed is STAT3; the disease is neoplasm.